Annual SG&A
$1.55 B
+$417.00 M+36.84%
31 December 2023
Summary:
Moderna annual selling, general & administrative expenses is currently $1.55 billion, with the most recent change of +$417.00 million (+36.84%) on 31 December 2023. During the last 3 years, it has risen by +$1.36 billion (+723.94%). MRNA annual SG&A is now at all-time high.MRNA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$281.00 M
+$13.00 M+4.85%
30 September 2024
Summary:
Moderna quarterly selling, general & administrative expenses is currently $281.00 million, with the most recent change of +$13.00 million (+4.85%) on 30 September 2024. Over the past year, it has dropped by -$161.00 million (-36.43%). MRNA quarterly SG&A is now -40.21% below its all-time high of $470.00 million, reached on 31 December 2023.MRNA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$48.35 B
-$2.22 B-4.40%
30 September 2024
Summary:
Moderna TTM selling, general & administrative expenses is currently $48.35 billion, with the most recent change of -$2.22 billion (-4.40%) on 30 September 2024. Over the past year, it has increased by +$46.90 billion (+3225.58%). MRNA TTM SG&A is now -31.50% below its all-time high of $1.55 billion, reached on 31 December 2023.MRNA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.8% | -36.4% | +3225.6% |
| 3 y3 years | +723.9% | +67.3% | +10000.0% |
| 5 y5 years | +1543.5% | +897.4% | +10000.0% |
MRNA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +723.9% | -40.2% | +67.3% | -31.5% | +1250.7% |
| 5 y | 5 years | at high | +1543.5% | -40.2% | +1070.8% | -31.5% | +738.5% |
| alltime | all time | at high | >+9999.0% | -40.2% | >+9999.0% | -31.5% | +738.5% |
Moderna Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $281.00 M(+4.9%) | $1.29 B(-11.1%) |
| June 2024 | - | $268.00 M(-2.2%) | $1.45 B(-4.2%) |
| Mar 2024 | - | $274.00 M(-41.7%) | $1.52 B(-2.0%) |
| Dec 2023 | $1.55 B(+36.8%) | $470.00 M(+6.3%) | $1.55 B(+6.5%) |
| Sept 2023 | - | $442.00 M(+33.1%) | $1.45 B(+12.7%) |
| June 2023 | - | $332.00 M(+8.9%) | $1.29 B(+10.4%) |
| Mar 2023 | - | $305.00 M(-18.7%) | $1.17 B(+3.3%) |
| Dec 2022 | $1.13 B(+99.6%) | $375.00 M(+34.9%) | $1.13 B(+18.2%) |
| Sept 2022 | - | $278.00 M(+31.8%) | $958.00 M(+13.0%) |
| June 2022 | - | $211.00 M(-21.3%) | $848.00 M(+11.9%) |
| Mar 2022 | - | $268.00 M(+33.3%) | $758.00 M(+33.7%) |
| Dec 2021 | $567.00 M(+201.6%) | $201.00 M(+19.6%) | $567.00 M(+27.4%) |
| Sept 2021 | - | $168.00 M(+38.8%) | $445.00 M(+36.9%) |
| June 2021 | - | $121.00 M(+57.1%) | $325.00 M(+34.9%) |
| Mar 2021 | - | $77.00 M(-2.5%) | $241.00 M(+28.2%) |
| Dec 2020 | $188.00 M(+70.9%) | $79.00 M(+64.6%) | $188.00 M(+39.2%) |
| Sept 2020 | - | $48.00 M(+29.7%) | $135.09 M(+17.2%) |
| June 2020 | - | $37.00 M(+54.2%) | $115.26 M(+8.0%) |
| Mar 2020 | - | $24.00 M(-8.0%) | $106.75 M(-3.0%) |
| Dec 2019 | $110.00 M(+16.7%) | $26.09 M(-7.4%) | $110.00 M(-9.8%) |
| Sept 2019 | - | $28.17 M(-1.1%) | $121.94 M(+8.6%) |
| June 2019 | - | $28.49 M(+4.5%) | $112.29 M(+6.7%) |
| Mar 2019 | - | $27.25 M(-28.3%) | $105.19 M(+11.6%) |
| Dec 2018 | $94.25 M(+45.6%) | $38.02 M(+105.3%) | $94.25 M(+30.7%) |
| Sept 2018 | - | $18.52 M(-13.4%) | $72.13 M(+32.9%) |
| June 2018 | - | $21.39 M(+31.1%) | $54.29 M(+63.0%) |
| Mar 2018 | - | $16.32 M(+2.6%) | $33.30 M(+87.3%) |
| Dec 2017 | $64.72 M(+12.7%) | $15.90 M(+2238.6%) | $17.78 M(+700.4%) |
| Sept 2017 | - | $680.10 K(+68.8%) | $2.22 M(+39.8%) |
| June 2017 | - | $402.80 K(-49.4%) | $1.59 M(+25.9%) |
| Mar 2017 | - | $795.40 K(+131.5%) | $1.26 M(+119.1%) |
| Dec 2016 | $57.45 M(+1385.3%) | - | - |
| Dec 2016 | - | $343.60 K(+629.5%) | $576.10 K(-30.2%) |
| Sept 2016 | - | $47.10 K(-38.2%) | $825.50 K(-54.1%) |
| June 2016 | - | $76.20 K(-30.2%) | $1.80 M(-35.6%) |
| Mar 2016 | - | $109.20 K(-81.6%) | $2.80 M(-25.4%) |
| Dec 2015 | $3.87 M(+16.0%) | $593.00 K(-42.0%) | $3.75 M(-4.3%) |
| Sept 2015 | - | $1.02 M(-4.7%) | $3.92 M(-9.5%) |
| June 2015 | - | $1.07 M(+1.0%) | $4.33 M(+11.6%) |
| Mar 2015 | - | $1.06 M(+39.4%) | $3.88 M(+16.3%) |
| Dec 2014 | $3.33 M(+88.9%) | $761.00 K(-46.9%) | $3.33 M(+5.7%) |
| Sept 2014 | - | $1.43 M(+130.5%) | $3.15 M(+37.6%) |
| June 2014 | - | $622.00 K(+20.3%) | $2.29 M(+10.6%) |
| Mar 2014 | - | $517.00 K(-10.9%) | $2.07 M(+17.4%) |
| Dec 2013 | $1.76 M(-66.4%) | $580.00 K(+1.2%) | $1.76 M(-43.6%) |
| Sept 2013 | - | $573.00 K(+42.5%) | $3.13 M(-0.8%) |
| June 2013 | - | $402.00 K(+91.4%) | $3.15 M(-15.8%) |
| Mar 2013 | - | $210.00 K(-89.2%) | $3.74 M(-28.7%) |
| Dec 2012 | $5.25 M(-37.3%) | $1.94 M(+225.1%) | $5.25 M(+1.5%) |
| Sept 2012 | - | $598.00 K(-39.7%) | $5.17 M(-19.5%) |
| June 2012 | - | $992.00 K(-42.2%) | $6.43 M(-21.5%) |
| Mar 2012 | - | $1.72 M(-8.0%) | $8.18 M(-2.2%) |
| Dec 2011 | $8.37 M(-19.2%) | $1.87 M(+0.8%) | $8.37 M(+3.3%) |
| Sept 2011 | - | $1.85 M(-32.6%) | $8.10 M(-20.6%) |
| June 2011 | - | $2.75 M(+44.4%) | $10.20 M(+5.2%) |
| Mar 2011 | - | $1.90 M(+19.2%) | $9.70 M(-6.3%) |
| Dec 2010 | $10.36 M(+2.7%) | $1.60 M(-59.7%) | $10.36 M(-6.0%) |
| Sept 2010 | - | $3.96 M(+76.0%) | $11.02 M(+4.5%) |
| June 2010 | - | $2.25 M(-12.2%) | $10.54 M(-0.0%) |
| Mar 2010 | - | $2.56 M(+13.6%) | $10.54 M(+4.5%) |
| Dec 2009 | $10.09 M | $2.25 M(-35.3%) | $10.09 M(-2.3%) |
| Sept 2009 | - | $3.48 M(+54.5%) | $10.32 M(+10.4%) |
| June 2009 | - | $2.25 M(+6.8%) | $9.35 M(-14.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | $2.11 M(-15.3%) | $10.92 M(-19.8%) |
| Dec 2008 | $13.62 M(-33.0%) | $2.49 M(-0.6%) | $13.62 M(-19.7%) |
| Sept 2008 | - | $2.50 M(-34.6%) | $16.95 M(-13.2%) |
| June 2008 | - | $3.83 M(-20.3%) | $19.54 M(-6.2%) |
| Mar 2008 | - | $4.80 M(-17.5%) | $20.83 M(+2.5%) |
| Dec 2007 | $20.31 M(+43.0%) | $5.82 M(+14.4%) | $20.31 M(+11.8%) |
| Sept 2007 | - | $5.09 M(-0.5%) | $18.17 M(+9.9%) |
| June 2007 | - | $5.12 M(+19.4%) | $16.53 M(+9.1%) |
| Mar 2007 | - | $4.29 M(+16.5%) | $15.15 M(+6.6%) |
| Dec 2006 | $14.21 M(+30.4%) | $3.68 M(+6.7%) | $14.21 M(+5.2%) |
| Sept 2006 | - | $3.45 M(-7.7%) | $13.51 M(+8.7%) |
| June 2006 | - | $3.74 M(+11.7%) | $12.43 M(+5.7%) |
| Mar 2006 | - | $3.35 M(+12.2%) | $11.76 M(+7.9%) |
| Dec 2005 | $10.89 M(+21.1%) | $2.98 M(+26.2%) | $10.89 M(+7.2%) |
| Sept 2005 | - | $2.36 M(-22.8%) | $10.16 M(-3.1%) |
| June 2005 | - | $3.06 M(+23.3%) | $10.48 M(+8.7%) |
| Mar 2005 | - | $2.48 M(+10.4%) | $9.64 M(+7.2%) |
| Dec 2004 | $9.00 M(+11.7%) | $2.25 M(-16.2%) | $9.00 M(-0.4%) |
| Sept 2004 | - | $2.69 M(+20.7%) | $9.03 M(+18.9%) |
| June 2004 | - | $2.22 M(+21.1%) | $7.60 M(-3.5%) |
| Mar 2004 | - | $1.84 M(-19.6%) | $7.87 M(-2.3%) |
| Dec 2003 | $8.06 M(-21.0%) | $2.29 M(+82.5%) | $8.06 M(-17.6%) |
| Sept 2003 | - | $1.25 M(-49.9%) | $9.78 M(-8.9%) |
| June 2003 | - | $2.50 M(+23.5%) | $10.73 M(+2.5%) |
| Mar 2003 | - | $2.02 M(-49.6%) | $10.47 M(+2.6%) |
| Dec 2002 | $10.20 M(+136.0%) | $4.01 M(+81.8%) | $10.20 M(+33.3%) |
| Sept 2002 | - | $2.21 M(-1.3%) | $7.65 M(+20.5%) |
| June 2002 | - | $2.23 M(+27.3%) | $6.35 M(+24.8%) |
| Mar 2002 | - | $1.76 M(+20.5%) | $5.09 M(+17.8%) |
| Dec 2001 | $4.32 M(-36.3%) | $1.46 M(+61.5%) | $4.32 M(-31.6%) |
| Sept 2001 | - | $902.00 K(-7.3%) | $6.32 M(-3.6%) |
| June 2001 | - | $973.00 K(-1.6%) | $6.56 M(-2.4%) |
| Mar 2001 | - | $989.00 K(-71.4%) | $6.72 M(-1.0%) |
| Dec 2000 | $6.79 M(+65.6%) | $3.46 M(+202.8%) | $6.79 M(+22.7%) |
| Sept 2000 | - | $1.14 M(+0.6%) | $5.54 M(+10.8%) |
| June 2000 | - | $1.13 M(+7.0%) | $4.99 M(-1.3%) |
| Mar 2000 | - | $1.06 M(-51.8%) | $5.06 M(+5.4%) |
| Dec 1999 | $4.10 M(+5.1%) | $2.20 M(+266.7%) | $4.80 M(+9.1%) |
| Sept 1999 | - | $600.00 K(-50.0%) | $4.40 M(+2.3%) |
| June 1999 | - | $1.20 M(+50.0%) | $4.30 M(-4.4%) |
| Mar 1999 | - | $800.00 K(-55.6%) | $4.50 M(-2.2%) |
| Dec 1998 | $3.90 M(-22.0%) | $1.80 M(+260.0%) | $4.60 M(+15.0%) |
| Sept 1998 | - | $500.00 K(-64.3%) | $4.00 M(-18.4%) |
| June 1998 | - | $1.40 M(+55.6%) | $4.90 M(-2.0%) |
| Mar 1998 | - | $900.00 K(-25.0%) | $5.00 M(0.0%) |
| Dec 1997 | $5.00 M(+257.1%) | $1.20 M(-14.3%) | $5.00 M(+31.6%) |
| Sept 1997 | - | $1.40 M(-6.7%) | $3.80 M(+18.8%) |
| June 1997 | - | $1.50 M(+66.7%) | $3.20 M(+23.1%) |
| Mar 1997 | - | $900.00 K(+12.5%) | $2.60 M(-7.1%) |
| Dec 1996 | $1.40 M(-46.2%) | - | - |
| Sept 1996 | - | $800.00 K(-11.1%) | $2.80 M(+7.7%) |
| June 1996 | $2.60 M(+23.8%) | $900.00 K(+50.0%) | $2.60 M(+13.0%) |
| Mar 1996 | - | $600.00 K(+20.0%) | $2.30 M(+4.5%) |
| Dec 1995 | - | $500.00 K(-16.7%) | $2.20 M(0.0%) |
| Sept 1995 | - | $600.00 K(0.0%) | $2.20 M(+4.8%) |
| June 1995 | $2.10 M(+425.0%) | $600.00 K(+20.0%) | $2.10 M(+31.3%) |
| Mar 1995 | - | $500.00 K(0.0%) | $1.60 M(+33.3%) |
| Dec 1994 | - | $500.00 K(0.0%) | $1.20 M(+50.0%) |
| Sept 1994 | - | $500.00 K(+400.0%) | $800.00 K(+33.3%) |
| June 1994 | $400.00 K | $100.00 K(0.0%) | $600.00 K(+20.0%) |
| Mar 1994 | - | $100.00 K(0.0%) | $500.00 K(+25.0%) |
| Dec 1993 | - | $100.00 K(-66.7%) | $400.00 K(+33.3%) |
| Sept 1993 | - | $300.00 K | $300.00 K |
FAQ
- What is Moderna annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Moderna?
- What is Moderna annual SG&A year-on-year change?
- What is Moderna quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Moderna?
- What is Moderna quarterly SG&A year-on-year change?
- What is Moderna TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Moderna?
- What is Moderna TTM SG&A year-on-year change?
What is Moderna annual selling, general & administrative expenses?
The current annual SG&A of MRNA is $1.55 B
What is the all time high annual SG&A for Moderna?
Moderna all-time high annual selling, general & administrative expenses is $1.55 B
What is Moderna annual SG&A year-on-year change?
Over the past year, MRNA annual selling, general & administrative expenses has changed by +$417.00 M (+36.84%)
What is Moderna quarterly selling, general & administrative expenses?
The current quarterly SG&A of MRNA is $281.00 M
What is the all time high quarterly SG&A for Moderna?
Moderna all-time high quarterly selling, general & administrative expenses is $470.00 M
What is Moderna quarterly SG&A year-on-year change?
Over the past year, MRNA quarterly selling, general & administrative expenses has changed by -$161.00 M (-36.43%)
What is Moderna TTM selling, general & administrative expenses?
The current TTM SG&A of MRNA is $48.35 B
What is the all time high TTM SG&A for Moderna?
Moderna all-time high TTM selling, general & administrative expenses is $1.55 B
What is Moderna TTM SG&A year-on-year change?
Over the past year, MRNA TTM selling, general & administrative expenses has changed by +$46.90 B (+3225.58%)